Injection Pen Market Report 2026

Injection Pen Market Overview

• Injection Pen market size has reached to $61.17 billion in 2025 • Expected to grow to $103.59 billion in 2030 at a compound annual growth rate (CAGR) of 11.1% • Growth Driver: Rising Disease Prevalence Fuels Growth Of Injection Pen Market • Market Trend: Novo Nordisk Introduces Wegovy Injection Pen For Effective Obesity Treatment • North America was the largest region in 2025.

What Is Covered Under Injection Pen Market?

Injection pens are used for injecting medication under the skin. Injection pens make injectable medicine such as insulin easier and more convenient to use, thus increasing patient adherence. The pens contain a cartridge, a dial to measure dosage, and a disposable needle and allow more simple, accurate, and convenient delivery than a vial and syringe. The main product types of injection pens are disposable injection pens and reusable injection pens. Disposable injection pens consist of a non-replaceable prefilled cartridge which is disposed of after being used. Reusable injection pens consist of a replaceable cartridge which can be discarded and replaced. Injection pens are used for various purposes such as diabetes, fertility, osteoporosis, growth hormone therapy, and other therapies by different end-users, including home care, hospitals, and clinics.

What Is The Injection Pen Market Growth Forecast?

The injection pen market size is expected to see rapid growth in the next few years. It will grow to $103.59 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to growing demand for home-based drug delivery, rising adoption of smart injection pens, expansion of chronic disease management programs, increasing focus on sustainability in medical devices, advancements in connected drug delivery systems. Major trends in the forecast period include increasing adoption of user-friendly injection devices, rising demand for disposable and prefilled pens, growing integration of dose accuracy and safety features, expansion of reusable and rechargeable injection pens, enhanced focus on patient adherence solutions.

Global Injection Pen Market Segmentation

1) By Product Type: Disposable Injection Pens, Reusable Injection Pens 2) By Therapy: Diabetes, Fertility, Osteoporosis, Growth Hormone Therapy, Other Therapies 3) By End Users: Home Care, Hospital And Clinics Subsegments: 1) By Disposable Injection Pens: Pre-filled Disposable Injection Pens, Single-Use Disposable Injection Pens 2) By Reusable Injection Pens: Refillable Injection Pens, Multi-Use Injection Pens, Rechargeable Injection Pens

What Is The Driver Of The Injection Pen Market?

The rise in the prevalence of diseases such as diabetes and arthritis is contributing to the growth of the injection pen market. Factors such as an increase in the size of the obese population, physical inactivity, unhealthy eating habits, and increasing age led to an increase in the global prevalence of diabetes. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-governmental, global advocacy organization focused on diabetes care, prevention, and research, 589 million adults (20-79 years) are living with diabetes globally, more than the population of the U.S., Canada, Mexico, and the Caribbean combined. The estimated number of adults with diabetes is projected to reach 853 million by 2050. Therefore, the rise in the prevalence of diseases such as diabetes and arthritis will drive the growth of the injection pen industry.

Key Players In The Global Injection Pen Market

Major companies operating in the injection pen market are Novo Nordisk A/S, Ypsomed Holding AG, Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Owen Mumford Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Ltd., Wockhardt Ltd., AptarGroup Inc., Novartis AG, Gerresheimer AG, SHL Medical AG, Boehringer Ingelheim International GmbH, Nemera France SA, Companion Medical Inc., Jiangsu Delfu Medical Devices Co. Ltd., Haselmeier GmbH, Biocon Limited, Becton Dickinson and Company, Mylan N.V., Terumo Corporation, West Pharmaceutical Services Inc., Bespak Europe Ltd., Nipro Corporation, Consort Medical plc, Sandoz Inc., Sulzer Ltd., DuPont de Nemours Inc., Mitsubishi Gas Chemical Company Inc.

Global Injection Pen Market Trends and Insights

Major companies operating in the injection pen market are focusing on innovating products, such as Wegovy, to provide reliable services to customers. Wegovy is used as an injection pen for treating patients with obesity and weight loss. For instance, in September 2023, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched Wegovy. Wegovy is an injection pen that contains the drug semaglutide. Wegovy helps patients reduce body weight by around 15% when used along with exercise and lifestyle changes.

What Are Latest Mergers And Acquisitions In The Injection Pen Market?

In September 2023, Abbott Laboratories, a US-based medical devices company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. With this acquisition, Abbott Laboratories aims to expand its portfolio in diabetes care with glucose monitoring technology and develop simple, affordable, and easy-to-use tools for people with diabetes. Bigfoot Biomedical Inc. is a California-based medical technology company that provides smart injection pens.

Regional Outlook

North America was the largest region in the injection pen market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Injection Pen Market?

The injection pen market consists of sales of disposable injection pens and reusable injection pens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.